Catalent Cts is a finished-dose manufacturer based in United Kingdom. It appears in 17 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), INVIMA (CO) and NPRA (MY). Its GMP standing is certified by ANVISA (Brazil), MHRA (UK) and NCELS (KZ). Its most recent recorded inspection, by US FDA, closed on 4 March 2022 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Kansas City, United Arab Emirates | Not on file |
| BATHGATE, United Kingdom | Not on file |
| SWINDON, United Kingdom | Not on file |
| United Kingdom, United Kingdom | 3009442470 |
| KANSAS CITY, United States | Not on file |
| Kansas City, United States | 3002929455 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 4 | None |
| INVIMA (CO) | 4 | None |
| NPRA (MY) | 3 | None |
| NCELS (KZ) | 2 | 1 |
| DIGEMAPS (DO) | 1 | None |
| EDE (AE) | 1 | None |
| ANVISA (Brazil) | None | 9 |
| MHRA (UK) | None | 6 |
Choose your molecules and target markets. Catalent Cts comes back tiered against every other supplier able to file there.
Start for free